DarolutamideApalutamideenzalutamidedarolutamidaARASENSandrogen deprivation therapy
…metastatic hormone-sensitive prostate cancer (mHSPC) (ARASENS). Darolutamide was commercialised in 2020.Aim and Objectives To evaluate the t…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: darolutamida ×
darolutamida
This drug is selected. Its supporting articles are shown below.